StockGuide AI
Track Stocks
EN RU ES
Walgreens

Walgreens

Price: 11.98

Company and Business Model

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Its core products include prescription medications, health and wellness products, and retail pharmacy services. Major business segments consist of Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The primary revenue sources are retail sales of pharmaceuticals and health products, along with pharmacy services.

Investment Profile

The investment profile of Walgreens is more aligned with value investors, given its current stock performance and market position. The company may appeal to those seeking stability rather than aggressive growth, as it faces challenges in profitability. The stock is suitable for medium to long-term horizons, with moderate liquidity.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
-7.29 Risk
Revenue QoQ — quarter-over-quarter revenue growth
1.0% ≈
EPS surprise
44.4% better than expected
20d volatility
0.6% stable
FMP / FinFeed data updated: 2026-06-09
Reco: Sell Potential: 40 Risk: 69 Updated: 2026-06-11 05:28
How recommendation works
Why AI thinks so:
Weak fundamentals and high risk; cautious approach advised.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-09 02:55 Hold Sell Weak fundamentals and high risk limit upside potential.
2026-06-01 02:54 Sell Hold Weak fundamentals and high risk limit upside potential.
2026-05-08 15:09 — Sell Weak fundamentals and high risk limit upside potential.